An innovative solution to the rising cost of drug-benefit plans
-
The cost of drug benefit plans is being driven up by the increasing number of claims for innovative, specialty medicines – which include biologics1,2
-
People with chronic inflammatory diseases may require a number of different brand name biologics and/or biosimilars over the course of their disease3,4
-
Biosimilars alone may not be the answer to drug plan sustainability2
Learn more about how the BIOLOGICS SAVINGS PARTNERSHIP™ may help to cut costs
With the BIOLOGICS SAVINGS PARTNERSHIP™ patients receive access to a variety of brand name biologics at a similar price as biosimilars
ASK YOUR INSURER IF THEY HAVE A BIOLOGICS SAVINGS PARTNERSHIP™ AGREEMENT